F. Richards

发表

A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.

J. Herndon, M. Green, G. Clamon, 1996, Lung cancer.

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer.

J. Tepper, L. Case, A. W. Blackstock, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improvement of long-term survival in extensive small-cell lung cancer.

L. Case, H. Muss, P. Zekan, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum. A prospective randomized study

C. Spurr, H. Muss, F. Richards, 1979, Cancer.

A phase I trial of ifosfamide, mesna, and cisplatin in advanced non‐small cell lung cancer a cancer and leukemia group B study

J. Herndon, Mark R. Green, M. Green, 1993, Cancer.

Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of bacillus calmette‐guerin (MER) in advanced breast cancer: A randomized trial by the piedmont oncology association

C. Spurr, H. Muss, M. Cooper, 1981, Cancer.

VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.

H. Muss, P. Zekan, F. Richards, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I T rial o f T wice-Weekly G emcitabine a nd C oncurrent Radiation i n P atients W ith A dvanced P ancreatic C ancer

J. Tepper, L. Case, A. W. Blackstock, 1999 .

Bone marrow evaluation in small cell lung cancer

C. Spurr, H. Muss, M. Cooper, 1984, American journal of clinical oncology.

Immunotherapy of small cell carcinoma of the lung (SCC): A randomized study

H. Muss, F. Richards, D. Jackson, 1979 .

Platinum-based combination chemotherapy in advanced non-small cell lung cancer: a randomized phase II trial of the Cancer and Leukemia Group B.

A. Kramar, M. Green, M. Stoopler, 1990, Medical and pediatric oncology.

Intravenous vincristine infusion: Phase I trial

C. Spurr, H. Muss, M. Cooper, 1981, Cancer.

Clinical trial of pyridoxine to reduce vincristine neurotoxicity

C. Spurr, J. Atkins, H. Muss, 2005, Journal of Neuro-Oncology.

Nonseminomatous germ cell cancer of the testis. Reducing treatment‐related morbidity in patients with disseminated disease

C. Spurr, H. Muss, M. Cooper, 1982 .

Recombinant gamma interferon in advanced breast cancer: A phase II trial

H. Muss, P. Zekan, M. Cooper, 2004, Investigational New Drugs.

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.

J. Herndon, D. Hollis, M. Green, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Twice-weekly gemcitabine and concurrent thoracic radiation for advanced non small-cell lung cancer.

G. Lesser, A. W. Blackstock, F. Richards, 1999, Clinical lung cancer.

Phase II trial of adjuvant radiation and intraperitoneal 5-fluorouracil for locally advanced colon cancer: results with 10-year follow-up.

K. Lohman, L. Case, A. W. Blackstock, 2000, International journal of radiation oncology, biology, physics.

Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B Study.

K. Propert, H. Kreisman, M. Green, 1987, Cancer treatment reports.

A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.

C. Spurr, L. Case, H. Muss, 1985, Cancer.

A randomized trial of adjuvant chemotherapy and immunotherapy in stage I and stage II cutaneous melanoma. An interim report

C. Spurr, L. Case, H. Muss, 1985 .

Sequential hemibody irradiation integrated into a chemotherapy-local radiotherapy program for limited disease small cell lung cancer.

L. Case, H. Muss, R. Choplin, 1986, International journal of radiation oncology, biology, physics.

Phase I study of concurrent radiation and twice-weekly gemcitabine in advanced pancreatic cancer

J. Tepper, S. Bernard, F. Richards, 1998 .

Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B Trial.

K. Propert, R. Weiss, M. Green, 1988, Medical and pediatric oncology.

Therapy of advanced colorectal carcinoma with 5‐fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate

C. Spurr, H. Muss, M. Cooper, 1980, Cancer.

High‐dose cyclophosphamide and 5‐fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast: A phase III study of the piedmont oncology association (POA)

C. Spurr, L. Case, H. Muss, 1984, Cancer.

Phase II study of pyrazine diazohydroxide (NSC 361456) for advanced non small-cell lung cancer.

G. Lesser, L. Case, F. Richards, 2000, Clinical lung cancer.

A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer

C. Spurr, J. Brockschmidt, H. Muss, 1991, Breast Cancer Research and Treatment.

A phase II trial of peg-L-asparaginase in the treatment of non-hodgkins lymphoma

C. Spurr, H. Muss, P. Zekan, 1990, Investigational New Drugs.

Vinblastine and 6-thioguanine in the treatment of advanced breast cancer.

C. Spurr, H. Muss, F. Richards, 1978, Cancer treatment reports.

A randomized trial of vincristine (V), adriamycin (A) and cyclophosphamide (C) versus low dose cyclophosphamide, methotrexate (M), and fluorouracil (F)

F. Richards, D. Jackson, H. Muss, 1981 .

Chemotherapy with 5‐fluorouracil (5‐FU) and cisplatin or 5‐FU, cisplatin, and vinblastine for advanced non‐small cell lung cancer. A randomized phase II study of the cancer and leukemia group B

E. Muchmore, F. Richards, MD David J. Perry, 1991, Cancer.